ARTICLE | Company News
Optimata, Eli Lilly deal
April 3, 2006 7:00 AM UTC
The companies are using Optimata's Virtual Patient technology to evaluate preclinical data for a cytotoxic cancer compound from LLY. The technology will be used to design clinical trials. ...